Transferases are one of the largest and most diverse families of enzymes in biology, responsible for moving a chemical group from one molecule to another. Phosphate groups, methyl groups, sugar chains, amino groups, acetyl tags: every time your cells need to attach one of these to a protein, a strand of DNA, a hormone, or a drug molecule, a transferase does the work. They show up in virtually every biological process you can name, from reading genes to digesting food to neutralizing toxins, and their malfunction sits at the center of diseases ranging from cancer to rare inherited metabolic disorders.
The Core Idea Behind Group Transfer
All transferases share a single conceptual job. They pick up a defined chemical group from a donor molecule and attach it to an acceptor molecule. The donor is often a small, energy-rich molecule the cell keeps in stock. Two of the most common donors are adenosine triphosphate (ATP), which donates phosphate groups, and S-adenosylmethionine (SAM), which donates methyl groups.1PubMed. Reagent Engineering for Group Transfer Biocatalysis The acceptor can be almost anything: another protein, a lipid, a strand of DNA, a steroid hormone, or a foreign chemical the body wants to get rid of.
Some transferases work through a two-step “ping-pong” mechanism: the enzyme first grabs the chemical group from the donor, forming a temporary bond with it, and then passes it to the acceptor in a second step. This has been demonstrated in detail for phosphoglycosyl transferases, where a covalent sugar-phosphate intermediate sits on the enzyme between the two half-reactions.2PubMed Central. Analysis of a dual domain phosphoglycosyl transferase reveals a ping-pong mechanism with a covalent enzyme intermediate A similar ping-pong mechanism has been shown for trans-sialidases, which shuttle sugar residues between molecules.3PubMed. Kinetic and mechanistic analysis of Trypanosoma cruzi trans-sialidase reveals a classical ping-pong mechanism with acid/base catalysis Other transferases work differently, bringing both the donor and the acceptor together in the active site at the same time before the group hops across. The mechanism varies, but the outcome is always the same: a chemical tag ends up in a new location, and that relocation changes what the acceptor molecule can do.
Kinases and the Phosphate Tag
Kinases are transferases that move a phosphate group from ATP onto a target protein (or sometimes a lipid or sugar). This phosphate tag acts like a molecular on/off switch. Adding a phosphate can activate a dormant signaling protein, or deactivate one that was running. The human genome encodes over 500 kinases, and together they orchestrate cell growth, division, movement, and death.
Structurally, kinases across vastly different organisms share what researchers call a “universal core” domain, consisting of the regions needed to bind ATP and carry out the phosphate transfer reaction. Despite enormous sequence variation over evolutionary time, that core architecture has been conserved from bacteria to humans.4PubMed Central. Structural evolution of the protein kinase-like superfamily Even the receptor tyrosine kinases, a large subgroup that sits on cell surfaces and responds to growth signals, show more structural similarity across families than researchers initially expected.5bioRxiv. Structural conservation and divergence across the Receptor Tyrosine Kinase superfamily
The phosphate transfer itself happens fast once the enzyme locks into the right shape. Computational studies of cAMP-dependent protein kinase (a well-studied model kinase) show that when the active site is in its “transition-state conformation,” the energy barrier for moving the phosphate is only about 20 kJ/mol, and the reaction is nearly reversible. But when the enzyme is in its open, resting conformation, that same reaction becomes energetically unfavorable by about 120 kJ/mol. The difference comes down to movements of just a few tenths of an angstrom in the catalytic site, meaning the enzyme essentially gates the reaction by snapping shut around its substrates.6PubMed Central. Conformational dependence of a protein kinase phosphate transfer reaction Crystallographic work has even caught the transfer mid-act: one crystal structure showed roughly half the enzyme molecules with the phosphate still on ATP and half with it already transferred to the target peptide.7PubMed Central. Phosphoryl transfer by protein kinase A is captured in a crystal lattice
When Kinases Go Wrong and How Drugs Target Them
Because kinases control cell growth signals, they are frequently hijacked in cancer. Receptor tyrosine kinases on the cell surface can become abnormally active through mutations, gene amplification, or other changes, sending constant “grow and survive” signals into the cell even when no growth factor is present.8Nature. Therapeutic advances of targeting receptor tyrosine kinases in cancer This makes them attractive drug targets. Small-molecule kinase inhibitors, drugs designed to block the phosphate-transfer activity of specific kinases, have become a cornerstone of modern cancer therapy. They offer a more targeted approach than traditional chemotherapy because they home in on the specific signaling defect driving a particular tumor.9PubMed Central. Recent developments in receptor tyrosine kinase inhibitors: A promising mainstay in targeted cancer therapy Imatinib, the drug that transformed chronic myeloid leukemia from a near-certain death sentence into a manageable chronic condition, works by blocking a single overactive kinase.
Methyltransferases and Epigenetic Control
While kinases tag proteins with phosphate, methyltransferases tag DNA and histone proteins with methyl groups, one-carbon units drawn from S-adenosylmethionine (SAM). SAM is produced through the folate and methionine metabolic cycles, which means that the supply of methyl groups for these reactions fluctuates based on diet and nutrient availability.10PubMed Central. One-carbon metabolism and epigenetics: understanding the specificity This creates a direct link between what you eat and how your genes are regulated.
Methyl marks on DNA typically silence genes, while methyl marks on histones (the spool-like proteins that DNA wraps around) can either activate or silence nearby genes depending on exactly which amino acid on the histone gets tagged. The pattern of these marks across the genome forms a layer of information on top of the DNA sequence itself, often called the epigenetic code. Histone methyltransferases are sensitive to intracellular SAM levels, so when cells are nutrient-deprived or when folate metabolism is disrupted, the methylation landscape can shift, potentially changing which genes are turned on or off.11PubMed Central. One-carbon metabolism and epigenetics: understanding the specificity Researchers studying cancer, aging, and developmental biology pay close attention to methyltransferases for exactly this reason.
Acetyltransferases and the Opening of Chromatin
Histone acetyltransferases (HATs) perform a complementary job: they attach acetyl groups to histone proteins. Where methyl marks can tighten or loosen the DNA packaging depending on context, acetyl marks generally loosen it, making genes more accessible for reading. The functions of HAT complexes extend well beyond gene activation, though. They participate in gene silencing, DNA repair, and cell-cycle progression.12Trends in Genetics. The diverse functions of histone acetyltransferase complexes
HATs do not work alone. They operate within large multi-protein complexes. TRRAP, for example, is a scaffolding protein found in several of these complexes, and its loss alters the acetylation of histones H3 and H4 at specific genes in a way that depends on which gene and which stage of the cell cycle the cell is in.13PubMed Central. Genome-wide analysis of gene expression regulated by the HAT cofactor Trrap in conditional knockout cells Another well-studied HAT, KAT2A, works with the general transcription machinery to acetylate histone H3 at a specific position (lysine 9), helping recruit the proteins that initiate gene transcription.14Nature Communications. Functional interplay between TFIIH and KAT2A regulates higher-order chromatin structure and class II gene expression Some acetyltransferases even regulate themselves: the yeast enzyme Rtt109, for instance, must acetylate one of its own lysine residues before it becomes catalytically active, a built-in safety switch that prevents premature activity.15PubMed Central. Molecular basis for the autoregulation of the protein acetyl transferase Rtt109
Transaminases in the Clinic and the Factory
Transaminases (also called aminotransferases) transfer amino groups between molecules, and they are among the most familiar transferases to anyone who has had a blood test. Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) are the most commonly used markers for liver injury.16PubMed Central. The past and present of serum aminotransferases and the future of liver injury biomarkers When liver cells are damaged, these enzymes leak into the bloodstream, so elevated ALT or AST on a routine panel prompts doctors to investigate liver health.
Outside the clinic, transaminases have become workhorses in industrial chemistry. They use pyridoxal 5′-phosphate (a form of vitamin B6) as a helper molecule to shuttle amino groups between substrates with high selectivity, meaning they preferentially produce one mirror-image form of a molecule over the other.17PubMed. Biochemical and structural insights into PLP fold type IV transaminase from Thermobaculum terrenum This matters enormously in drug manufacturing, where the left-handed and right-handed versions of a molecule can have completely different biological effects. Amine transaminases can carry out these reactions without relying on expensive cofactors that need to be regenerated, making them attractive for green chemistry approaches to pharmaceutical production.18PubMed. Transaminases for chiral amine synthesis
A long-standing practical challenge has been that many transaminase reactions reach an unfavorable equilibrium, meaning the product tends to convert back to the starting material. Researchers have addressed this by developing clever donor molecules. One approach uses ortho-xylylenediamine as the amino-group donor; the by-product it generates spontaneously polymerizes and becomes colored, which simultaneously drives the reaction forward and provides a visual readout for high-throughput screening of new transaminase variants.19PubMed Central. Chiral amine synthesis using ω-transaminases: an amine donor that displaces equilibria and enables high-throughput screening
Glycosyltransferases and Sugar Coats
Glycosyltransferases attach sugar molecules to proteins, lipids, and other sugars. The sugar coating on a protein is not decorative; it determines how the protein folds, how long it lasts in the bloodstream, and how the immune system recognizes it. N-glycosyltransferases, for example, recognize a specific short amino-acid sequence on a protein and attach a sugar chain to the nitrogen atom of an asparagine residue within that sequence.20PubMed Central. In Vitro Glycosylation of Membrane Proteins Using N-Glycosyltransferase
When the genes encoding glycosyltransferases carry inherited mutations, the result can be a congenital disorder of glycosylation (CDG). More than 130 such disorders have been identified, typically inherited in an autosomal recessive pattern. They tend to affect multiple organ systems at once, with common features including growth failure, developmental delay, facial differences, and problems with blood clotting and hormone regulation.21PubMed Central. Congenital disorders of glycosylation Their multi-systemic nature reflects how fundamental glycosylation is: when the sugar-attaching machinery breaks, the effects ripple across nearly every tissue.
On the applied side, pharmaceutical companies are intensely interested in controlling glycosyltransferases to fine-tune therapeutic antibodies. The sugar pattern on an antibody’s constant region determines how strongly it can trigger immune-cell killing of target cells, a property called antibody-dependent cellular cytotoxicity (ADCC). By knocking out undesired glycosyltransferases and inserting desired ones in antibody-producing cell lines, researchers have generated antibodies with specific sugar patterns that bind immune receptors more effectively.22PubMed Central. Cell-based glycoengineering for production of homogeneous and specific glycoform-enriched antibodies with improved effector functions One strategy focuses specifically on removing a sugar called fucose from the antibody: knocking down the single glycosyltransferase responsible for adding core fucose has been shown to enhance ADCC activity of antibodies by 10- to 100-fold in some experimental systems.23Molecular Therapy. Glycoengineering of Adeno-Associated Virus-Delivered Antibodies Another approach uses yeast to produce the antibody trastuzumab (Herceptin), then enzymatically remodels its sugars in the test tube to generate a uniform product optimized for immune function.24PubMed Central. Glycoengineering of antibody (Herceptin) through yeast expression and in vitro enzymatic glycosylation
Detoxification Transferases
Not all transferases build things. Some exist primarily to neutralize threats. Glutathione S-transferases (GSTs) are a family of enzymes that conjugate the small molecule glutathione to toxic compounds, including carcinogens, environmental pollutants, chemotherapy drugs, and the byproducts of oxidative stress. Conjugation makes the toxin far more water-soluble and marks it for excretion.25PubMed. Role of glutathione S-transferases in detoxification of a polycyclic aromatic hydrocarbon, methylcholanthrene This is part of what pharmacologists call phase II metabolism, the stage where the body’s enzymes attach bulky, polar groups to foreign chemicals so they can be flushed out through urine or bile. GSTs are implicated in human disease partly because genetic variation in GST genes affects how efficiently different people clear toxins, and partly because tumor cells sometimes overexpress GSTs to resist chemotherapy drugs.26PubMed Central. The role of glutathione S-transferases in human disease pathogenesis and their current inhibitors
Sulfotransferases perform a parallel detoxification and regulatory role, transferring sulfate groups onto hormones, neurotransmitters, and drugs. Many steroid hormones, thyroid hormones, and catecholamines circulate primarily as sulfate conjugates in humans, and sulfation effectively inactivates them, serving as a buffer that regulates how much active hormone is available at any given time.27PubMed. Function and organization of the human cytosolic sulfotransferase (SULT) family
Transferases in Antibiotic Resistance
Bacteria have turned transferase activity into a weapon against antibiotics. The most common mechanism of resistance to aminoglycoside antibiotics (a class that includes gentamicin and tobramycin) involves enzymes that modify the drug molecule itself. These modifying enzymes are transferases: some phosphorylate the antibiotic, some adenylate it (attach an adenine-containing group), and some acetylate it. Each modification distorts the drug’s shape enough that it can no longer bind its target inside the bacterial ribosome.28PubMed. Aminoglycoside-modifying enzymes The genes encoding these transferases often sit on mobile genetic elements, which is why resistance spreads so rapidly between bacterial species. Understanding exactly how each modifying enzyme recognizes and alters the antibiotic has been a key focus in designing next-generation aminoglycosides that evade enzymatic modification.
Acyltransferases and Fat Storage
The transferases involved in lipid metabolism are less famous but no less consequential. Acyl-CoA:glycerol-3-phosphate acyltransferase (GPAT) catalyzes the first committed step in the synthesis of triacylglycerols, the primary form of stored fat in your body. When researchers identified and overexpressed a specific isoform called GPAT3 in mammalian cells, the cells accumulated more triacylglycerol without a corresponding increase in membrane phospholipids, confirming that this particular transferase is specifically dedicated to fat storage rather than membrane building.29PubMed Central. Molecular identification of microsomal acyl-CoA:glycerol-3-phosphate acyltransferase, a key enzyme in de novo triacylglycerol synthesis This kind of specificity is characteristic of transferases generally: even though they all perform the same conceptual operation (move a group from A to B), each one is tuned to a particular donor, a particular acceptor, and a particular biological context.
The Ribosome as a Transferase
Perhaps the most surprising transferase in biology is not a protein at all. The ribosome, the molecular machine that assembles proteins in every living cell, catalyzes peptidyl transfer: it moves a growing peptide chain from one transfer RNA molecule onto the amino acid attached to the next. High-resolution structures of the large ribosomal subunit revealed that no protein side chain comes within about 18 angstroms of where the new peptide bond forms. The active site is made entirely of ribosomal RNA.30PubMed. The structural basis of ribosome activity in peptide bond synthesis The ribosome, in other words, is a ribozyme: an RNA molecule that catalyzes a chemical reaction.
Laboratory experiments have reinforced this idea by showing that synthetic RNA molecules can be evolved in the test tube to catalyze the same kind of peptide-bond formation. One such ribozyme turned out to have a sequence and secondary structure strikingly similar to the region of natural ribosomal RNA that performs peptidyl transfer.31Chemistry & Biology. Peptidyl-transferase ribozymes: trans reactions, structural characterization and ribosomal RNA-like features This convergence supports the idea that the transferase activity at the heart of protein synthesis is genuinely ancient, possibly predating protein enzymes entirely. It is a reminder that “transferase” describes a function, not a structural category. Whether built from protein, RNA, or some combination, the job is the same: move a chemical group from here to there, and in doing so, change what a molecule can do next.